2024 ICD-10-CM Diagnosis Code B48.1

by

Rhinosporidiosis

  • B48.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM B48.1 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of B48.1 – other international versions of ICD-10 B48.1 may differ.

The following code(s) above B48.1 contain annotation back-references

 that may be applicable to B48.1:

  • A00-B99  Certain infectious and parasitic diseases
  • B35-B49  Mycoses

Clinical Information

  • Chronic, localized granulomatous infection of mucocutaneous tissues, especially the nose, and characterized by hyperplasia and the development of polyps. It is found in humans and other animals and is caused by the mesomycetozoean organism rhinosporidium seeberi.

ICD-10-CM B48.1 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 867 Other infectious and parasitic diseases diagnoses with mcc
  • 868 Other infectious and parasitic diseases diagnoses with cc
  • 869 Other infectious and parasitic diseases diagnoses without cc/mcc

Convert B48.1 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change

Diagnosis Index entries containing back-references to B48.1: